期刊文献+

端粒、端粒酶结合因子hPinx1基因启动子的克隆及活性分析

Cloning and Activity Analysis of Telomere/Telomerase Binding Factor hPinx1 Promoter
在线阅读 下载PDF
导出
摘要 目的:克隆端粒、端粒酶结合因子hPinx1基因的启动子,分析并鉴定其活性调控元件。方法:采用PCR技术从人肝癌细胞系HepG2基因组中扩增出hPinx1启动子,构建到萤光素酶报告基因载体pGL3-basic中,确定所扩增的DNA序列,在HepG2细胞中检测其活性。结果:克隆了hPinx1基因转录起始位点上游4661bp且序列正确;活性分析表明hPinx1启动子含有多个调控元件,其中核心序列位于530bp内,在1329~2174bp间存在正调控序列,在2174~4661bp间存在负调控序列。结论:构建的hPinx1启动子具有活性,为hPinx1的功能研究提供了重要基础。 Objective: To clone telomere/telomerase binding factor hPinxl promoter and insert it into a luciferase reporter gene vector, and to characterize the promoter activity. Methods: The promoter of hPinxl was amplified from human liver cancer cell line HepG2 genomic DNA by PCR and constructed into pGL3-basic vector. The recombinant plasmid was determined by DNA sequencing. The promoter activity was analyzed in HepG2 cell line. Results: The upstream 4 661 bp of hPinxl transcriptional start site was constructed successfully. The hPinxl promoter contained many regulatory elements. The core region of hPinxl promoter located witnin 530 bp, there were a positive regulatory sequence from 1 329 to 2 174 bp , and a negative regulatory sequence from 2 174 to 4 661 bp. Conclusion: The activity assay confirmed that the sequence had promoter activity. This is important for hPinxl further function investigation.
出处 《生物技术通讯》 CAS 2008年第5期645-648,共4页 Letters in Biotechnology
关键词 hPinx1启动子 萤光素酶报告基因 转录活性 端粒 端粒酶 hPinx1 promoter luciferasse reporter gene transcriptional activity telomere telomerase
  • 相关文献

参考文献5

  • 1Zhou Xiao Zhen, Lu Kun Ping. The Pin2/TRF-interacting protein PinX1 is a protent telomerase inhibitor[J]. Cell, 2001,107:347.
  • 2Feng J, et al. The TNA component of human telomerase[J]. Science, 1995,269:1236.
  • 3陈皓,黄君健,张惟材.靶向端粒酶的肿瘤治疗方案相关进展[J].生物技术通讯,2007,18(4):674-676. 被引量:1
  • 4杨平勋,黄君健.端粒及端粒酶的研究进展[J].生物技术通讯,2007,18(4):667-669. 被引量:3
  • 5Wang Suiquan, Liao Cheng. Cloning and characterization of the pomoter region of human LPT S/PinX1 gene[J]. Biochim Biophys Acta, 2004,1676:261-265.

二级参考文献24

  • 1Ru-xianLIN,Chao-weiTUO,Qiu-junLUE,WeiZHANG,Sheng-qiWANG.Inhibition of tumor growth and metastasis with antisense oligonucleotides (Cantide) targeting hTERT in an in situ human hepatocellular carcinoma model[J].Acta Pharmacologica Sinica,2005,26(6):762-768. 被引量:14
  • 2Campisi J,Kim Sahn-Ho,Lim Chang-Su,et al.Cellular senescence,cancer and aging; the telomere connection[J].Experimental Gerontology,2001,36:1619.
  • 3Greider CW.Telomere length regulation[J].Annu Rev Biochem,1996,65:337.
  • 4Mergny JL,Riou JF.Survey and summary natural and pharmacological regulation of telomerase[J].Nucleic Acids Res,2002,30(4):839.
  • 5Blackburn EH.Telomere states and cell fates[J].Nature,2000,408:53.
  • 6Hackett JA,Gredier CW.Balancing instability;dual roles for telomerase and telomere dysfunction in tumorigensis[J].Oncogene,2002,21:619.
  • 7Karlseder J,Broccoli D,Dai Y,et al.TRF2 protects telomeres from end-to-end fusions[J].Cell,1998,92:401.
  • 8van Steensel B.Control of human telomere length by TRF1 and TRF2[J].Mol Cell Biol,2000,20(5):1659.
  • 9Baumann P,Podell P,Cech TR.Human Potl(Protection of Telomeres) protein:Cytolocalization,gene structure,and alternative splicing[J].Mol Cell Biol,2002,20:8079.
  • 10Baumann P,Cech TR.Potl,the putative telomere end-binding protein in fission yeast and humans[J].Science,2001,292(5519):1171.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部